carbamates has been researched along with arginine vasopressin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isono, K; Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J; Yamawaki, I | 1 |
| Brueggemann, LI; Byron, KL; Kumar, L; Mani, BK; O'Dowd, J; Ross, M | 1 |
2 other study(ies) available for carbamates and arginine vasopressin
| Article | Year |
|---|---|
A human bronchial epithelial cell line releases arginine vasopressin: involvement of Ca2+ -activated K+ channels.
Topics: Arginine Vasopressin; Bradykinin; Bronchi; Carbamates; Cell Line; Epithelial Cells; Humans; Large-Conductance Calcium-Activated Potassium Channels; Peptides; Phenylcarbamates; Platelet Activating Factor; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Type C Phospholipases | 1998 |
Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm.
Topics: Animals; Anthracenes; Arginine Vasopressin; Basilar Artery; Carbamates; Celecoxib; Disease Models, Animal; Endothelin-1; KCNQ Potassium Channels; Male; Membrane Transport Modulators; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myography; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Pyrazoles; Rats; Rats, Sprague-Dawley; Serotonin; Signal Transduction; Subarachnoid Hemorrhage; Sulfonamides; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasospasm, Intracranial | 2013 |